|
Volumn 10, Issue 1, 2016, Pages 112-115
|
Diagnostic and treatment options for severe IBD in female X-CGD carriers with non-random X-inactivation
|
Author keywords
Allogeneic haematopoietic stem cell transplantation; Inflammatory bowel disease; X chromosomal chronic granulomatous disease
|
Indexed keywords
ADALIMUMAB;
ALEMTUZUMAB;
AMOXICILLIN;
AZATHIOPRINE;
BUSULFAN;
CD163 ANTIGEN;
CHLORDANE;
CITALOPRAM;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
DIHYDRORHODAMINE 123;
DOXORUBICIN;
DOXYCYCLINE;
FLUDARABINE;
INFLIXIMAB;
METHOTREXATE;
METRONIDAZOLE;
MYCOPHENOLATE MOFETIL;
PREDNISONE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
RITUXIMAB;
VINCRISTINE;
CYBB PROTEIN, HUMAN;
MEMBRANE PROTEIN;
ADULT;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA;
ANUS FISTULA;
ARTICLE;
AUTOIMMUNITY;
BLOODY DIARRHEA;
CACHEXIA;
CASE REPORT;
CELL AGING;
CHILD;
CHRONIC GRANULOMATOUS DISEASE;
COLITIS;
COLON BIOPSY;
COLONOSCOPY;
COMBINATION CHEMOTHERAPY;
CORTICOSTEROID THERAPY;
CROHN DISEASE;
DISEASE SEVERITY;
DRUG WITHDRAWAL;
ENTERIC FEEDING;
ENZYME ACTIVITY;
FECES INCONTINENCE;
FEMALE;
FEVER;
FOLLOW UP;
GASTROINTESTINAL BIOPSY;
GENE SEQUENCE;
GRAFT VERSUS HOST REACTION;
HEALING;
HETEROZYGOTE;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
IMMUNOPHENOTYPING;
IMMUNOSUPPRESSIVE TREATMENT;
INFLAMMATORY BOWEL DISEASE;
MACROPHAGE;
MISSENSE MUTATION;
MOLECULAR GENETICS;
MUCOSAL HEALING;
MYELOABLATIVE CONDITIONING;
OSTEOPOROSIS;
PANCOLITIS;
PRIORITY JOURNAL;
PROCTITIS;
QUALITY OF LIFE;
REACTIVE DEPRESSION;
REMISSION;
SCHOOL CHILD;
X CHROMOSOME INACTIVATION;
X LINKED CHRONIC GRANULOMATOUS DISEASE;
YOUNG ADULT;
ALLOGRAFT;
EPIDEMIOLOGY;
GENETIC PREDISPOSITION;
GENETICS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
NEEDLE BIOPSY;
PATHOLOGY;
PROCEDURES;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
ADULT;
ALLOGRAFTS;
BIOPSY, NEEDLE;
CROHN DISEASE;
FEMALE;
FOLLOW-UP STUDIES;
GENETIC PREDISPOSITION TO DISEASE;
GRANULOMATOUS DISEASE, CHRONIC;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HETEROZYGOTE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MEMBRANE GLYCOPROTEINS;
MUTATION, MISSENSE;
NADPH OXIDASE;
RISK ASSESSMENT;
SAMPLING STUDIES;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
X CHROMOSOME INACTIVATION;
YOUNG ADULT;
|
EID: 84963729153
PISSN: 18739946
EISSN: 18764479
Source Type: Journal
DOI: 10.1093/ecco-jcc/jjv186 Document Type: Article |
Times cited : (31)
|
References (15)
|